Beam Therapeutics Inc. Q4 2025 Earnings Call Summary

Beam plans to utilize an 'umbrella' clinical trial design, allowing multiple mutation-specific base editors to be developed ...
GEN - Genetic Engineering and Biotechnology News

Beam Designs New Approach for Direct Correction of Mutations Causing PKU

Beam is advancing BEAM-304 using an approach in which multiple mutation-specific base editors are developed within a single clinical program.

Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will announce its fourth quarter and full ...

Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, ...
Nasdaq

Beam Therapeutics to Highlight New Data from BEAM-101 Program in Sickle Cell Disease at European Hematology Association (EHA) 2025 Congress

CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
WBAY

BEAM program promotes healing through the arts

GREEN BAY, Wis. (WBAY) - Across our community, you’ll find unsung heroes giving of their time, talent and treasures to make Northeast Wisconsin a great place to live. WBAY is excited to begin a new ...
Hartford Courant

CT-based health plan donates period supplies to The Diaper Bank of Connecticut’s Beam program

ConnectiCare has made a donation of “more than 80 boxes of pads, tampons, and other period supplies to The Diaper Bank of Connecticut’s (CT) Beam program,” according to a statement. “Everyone deserves ...